On the other hand, CR may impact the obesity-cancer pathway, by reducing serum insulin, leptin, and associated inflammation by limiting NFκβ—related gene expression [157, 158]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.